Ipatasertib + atezolizumab for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Aug 2018: Trial started, NCT03673787
  2. 17 Sep 2018: Trial registered, NCT03673787

The trials

NCT03673787: A Trial of Ipatasertib in Combination With Atezolizumab

State
Under way
Phase
Phase 1 and Phase 2
People
87 planned
Started
13 Aug 2018
Primary completion
Mar 2026
Arms
Phase I, Phase II
Results
None posted
  1. 13 Aug 2018: Trial started
  2. 17 Sep 2018: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.